Larvol Delta - A-Phase-II-Study-of-H021-Entericcoated-Tablets-for-Moderately-to-Severely-Active-Crohn39s-Disease

H-021 - Carephar Pharma

http://clinicaltrials.gov/ct2/show/NCT07677514

Jul 1, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next